Braunstein and Richter Talk Transplant and Therapy Options in Newly Diagnosed Myeloma

Season 4 Episode 21  ·  Jan 07, 2021, 09:44 PM
Headliner
Share
Subscribe

In our exclusive interview, Dr. Braunstein and Dr. Richter discuss navigating treatment selection for patients with newly diagnosed multiple myeloma and the evolving role of minimal residual disease.

Share
Subscribe
Next
Powles and Rini Put ctDNA Into Perspective in Urothelial Cancer
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air